Pharma’s broken business model: An industry on the brink of terminal decline
Biotech Voices is a contributed article from select Endpoints News readers. Commentator Kelvin Stott regularly blogs about the ROI in pharma. You can read more from him here. Like many industries, pharma’s business model fundamentally depends on productive innovation to create value by delivering greater customer benefits. Further, sustainable growth and value creation depend on steady R&D productivity with a … Continue reading Pharma’s broken business model: An industry on the brink of terminal decline
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed